Aurora Cannabis Inc.

NASDAQ: ACB · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Edmonton, ABCIK 0001683541Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 69

v0.1 · 5/100 weight · pillars only

↑ workforce scale, return on assets · ↓ filing timeliness, Altman-Z

Methodology →

Revenue TTM

$224.6M

Rev growth YoY (TTM)

-8.9%

Net income (FY)

$1.1M

Employees

1,073

Market cap

$175.9M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income$1.1M1.6M CAD2025

Total assets$593.1M852.7M CAD2025

Liabilities$169.8M244.1M CAD2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Aurora Cannabis Inc. earned $1.1M in FY2025 net income.

Peers · Healthcare

Stereotaxis, Inc.55C Auxly Cannabis Group Inc.76B+Coherus Oncology, Inc.62C NervGen Pharma Corp. Common stock——

Key facts

CEOMiguel Martin

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersEdmonton, AB

ExchangeNASDAQ: ACB

Employees1,073

IPO date2014-07-15

Latest filings

6-K2026-07-09 6-K2026-07-09 6-K2026-07-08 6-K2026-06-11 40-F2026-06-11 6-K2026-05-28 6-K2026-05-21 6-K2026-05-14

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.